FDA Import Refusal 605-1163450-7/11/1 — Millmount Healthcare Ltd.
The FDA refused shipment 605-1163450-7/11/1 from Millmount Healthcare Ltd. (Ireland) on October 31, 2022. The refused product falls under Drugs and Biologics — RITUXIMAB (ANTI-NEOPLASTIC - PART II). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- October 31, 2022
- Country
- Ireland
- Product Category
- Drugs and Biologics
- Product Code
- 62ZIK34 RITUXIMAB (ANTI-NEOPLASTIC - PART II)
- Charges
- 75